MedPath

Clinical study on the treatment of cervical spondylosis by

Not Applicable
Conditions
Cervical spondylosis
Registration Number
ITMCTR2200006850
Lead Sponsor
Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Hospital of Traditional Chinese Medicine)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

2.1 In line with Western medicine diagnostic standards for cervical spondylosis, X-ray, CT, MRI and other imaging data of cervical vertebra open mouth were complete;
2.2 Age range from 20 to 70;
2.3 A washout period of more than 5 days for patients with cervical spondylosis who have received other treatments;
2.4 Willing to accept TCM bone-setting treatment;
2.5 Good compliance, signed informed consent to ensure that the implementation of the program during the test;
2.6 The oral radiographs of the patient's cervical spine indicated that the atlantodental space gap was greater than 0.5MM.

Exclusion Criteria

3.1 Cervical spondylotic radiculopathy with surgical indications shall be excluded. ?
3.2 Patients with systemic bone and joint diseases, cervical tumor and tuberculosis, severe cervical trauma or cervical surgery history that may affect the results of the study;
3.3 Patients with vertebral artery cervical vertigo attack who could not take care of themselves;
3.4 Complicated with serious primary diseases of heart, cerebrovascular, liver, kidney, hematopoietic system, endocrine system and mental disorders;
3.5 The injured skin is damaged, or other diseases affect the injured local massage treatment, such as skin diseases;
3.6 Women who are breastfeeding, pregnant or preparing to become pregnant;
3.7 Patients who are participating in clinical trials of other drugs;
3.8 In addition to cervical spondylosis, pain relievers (such as acetaminophen, non-steroidal anti-inflammatory drugs, compound over-the-counter drugs containing analgesic ingredients, Chinese medicines that may contain analgesic active ingredients, local pain relievers) are needed for other chronic or recurrent pain;
3.9 Other diseases or conditions that could reduce or complicate enrollment, such as frequent changes in the working environment, could easily cause loss of follow-up as determined by the investigator.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eck Disfunction Index;fMRI;
Secondary Outcome Measures
NameTimeMethod
Cervical Range of Motion;Visual Analog Scales;
© Copyright 2025. All Rights Reserved by MedPath